|
Organization and Basis of Presentation - Additional Information (Detail) (USD $)
In Thousands, except Share data, unless otherwise specified |
1 Months Ended | 1 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Mar. 26, 2014
|
Aug. 13, 2013
|
Jul. 26, 2013
|
Mar. 31, 2014
|
Dec. 31, 2013
|
Mar. 31, 2014
AquaBounty
|
Mar. 31, 2014
BioPop
|
Oct. 31, 2013
BioPop
|
Aug. 13, 2013
IPO
|
Aug. 13, 2013
Exercise of Overallotment Option by Underwriters
|
|
| Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items] | ||||||||||
| Percentage of outstanding common stock acquired | 60.00% | 51.00% | 51.00% | |||||||
| Reverse stock split ratio | 1-for-1.75 | |||||||||
| Reverse stock split ratio | 0.57143 | |||||||||
| Shares of common stock | 972,004 | 11,499,998 | 1,499,999 | |||||||
| Price per share of common stock | $ 25.72 | $ 16.00 | ||||||||
| Aggregate proceeds from the IPO | $ 168,300 | |||||||||
| Underwriting discounts and commissions | 12,900 | |||||||||
| Offering Expense paid | 2,800 | |||||||||
| Capitalized expenses | $ 2,300 | |||||||||
| Shares of common stock | 79,705,130 | |||||||||
| Number of authorized shares of common stock | 200,000,000 | 200,000,000 | 200,000,000 | |||||||
| Number of authorized shares of preferred stock | 25,000,000 | |||||||||